Story perspectives

COVID Vaccination Cuts Preeclampsia Risk by 33% in Pregnancy

2/20/2026

Summary

Story summary

Coronavirus disease 2019 (COVID-19) vaccination during pregnancy reduces preeclampsia risk by 33% in a study of 6,527 pregnant women across 18 countries; booster doses enhance the effect.
Women with pre-existing conditions saw a 58% reduction in preeclampsia risk when vaccinated during pregnancy.
Vaccination transfers protective antibodies to infants, improving maternal and neonatal health.
The findings support integrating COVID-19 vaccines into prenatal care and confirm safety at any pregnancy stage.

1 of 1

Story summary

Coronavirus disease 2019 (COVID-19) vaccination during pregnancy reduces preeclampsia risk by 33% in a study of 6,527 pregnant women across 18 countries; booster doses enhance the effect.
Women with pre-existing conditions saw a 58% reduction in preeclampsia risk when vaccinated during pregnancy.
Vaccination transfers protective antibodies to infants, improving maternal and neonatal health.
The findings support integrating COVID-19 vaccines into prenatal care and confirm safety at any pregnancy stage.